📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BRAF inhibitors: resistance and the promise of combination treatments for melanoma. (2017)

First Author: Griffin M

Attributed to: Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.19836

PubMed Identifier: 29100459

Publication URI: http://europepmc.org/abstract/MED/29100459

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 44

ISSN: 1949-2553